Karin Hecht

High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML)

Michaela Graf, Susanne Reif, Karin Hecht et al. · Annals of Hematology · 2004 · 72 citations

Hematological Malignancy, Costimulatory Molecules, Mixed-phenotype Acute Leukemia +10

Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies

Michaela Graf, Karin Hecht, Susanne Reif et al. · European Journal Of Haematology · 2004 · 72 citations

Expression of MAC‐1 (CD11b) in acute myeloid leukemia (AML) is associated with an unfavorable prognosis

Michaela Graf, Susanne Reif, Tanja Kröll et al. · American Journal of Hematology · 2006 · 39 citations

High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis

Michaela Graf, Susanne Reif, Karin Hecht et al. · American Journal of Hematology · 2005 · 36 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Blood Cell +18

Use of NG2 (7.1) in AML as a tumor marker and its association with a poor prognosis.

Karin Petrovici, Michaela Graf, Karin Hecht et al. · PubMed · 2010 · 26 citations

Mixed-phenotype Acute Leukemia, Immunology, Pathology +19